Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis
Clinical trial NCT05072691 · RECRUITING
Trial details
- NCT number
- NCT05072691
- Sponsor
- Francis Corazza
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-14
- Primary completion
- 2030-01-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.